Beclomethasone Dipropionate(be kloe meth’ a sone)
Apo-Beclomethasone (CAN), Gen-Beclo AQ (CAN), OrbeShield, Propaderm (CAN), QNASL, QVAR, ratio-Beclomethasone AQ (CAN)
Beclomethasone Dipropionate Monohydrate
Beconase AQ
PREGNANCY CATEGORY C
Drug Classes
Corticosteroid
Glucocorticoid
Hormone
Therapeutic Actions
Anti-inflammatory effects; local administration into lower respiratory tract or nasal passages maximizes beneficial effects on these tissues while decreasing the likelihood of adverse corticosteroid effects from systemic absorption.
Indications
Maintenance and prophylactic treatment of asthma in patients 5 yr and older
NEW INDICATION: Treatment of GI acute radiation syndrome (OrbeShield); orphan drug use
Respiratory inhalant use: Control of bronchial asthma that requires corticosteroids along with other therapy
Intranasal use: Relief of symptoms of seasonal or perennial and nonallergic rhinitis that respond poorly to other treatments; prevention of recurrence of nasal polyps following surgical removal
Contraindications and Cautions
Respiratory inhalant therapy: Contraindicated with acute asthmatic attack, status asthmaticus. Use caution with systemic fungal infections (may cause exacerbations), allergy to any ingredient, status asthmaticus, lactation.
Intranasal therapy: Use caution with untreated local infections (may cause exacerbations); nasal septal ulcers, recurrent epistaxis, nasal surgery or trauma (interferes with healing); lactation.
Available Forms
Inhalation aerosol—40 mcg/actuation, 80 mcg/actuation; nasal spray—0.042% (42 mcg/inhalation); nasal aerosol—80 mcg/actuation
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
